Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Dig Dis Sci. 2016 Jun 1;61(10):2928–2934. doi: 10.1007/s10620-016-4204-4

Table 3.

Clinical Features of EoE Cases vs Controls (individuals without EoE):

Diagnoses EoE Cases, n (%) Controls, n (%)
GI Diagnoses1
GERD 5120 (65.3) 7,420,150 (10.2)
Heartburn 600 (7.6) 224,260 (0.7)
Dysphagia 6180 (78.8) 673,390 (2.2)
Esophageal stricture 1960 (25) 103,470 (0.3)
Chest pain 2110 (26.9) 3,293,360 (10.7)
Foreign body in
esophagus
920 (11.7) 28,230 (0.1)
Nausea and vomiting 1510 (19.3) 1,216,320 (3.9)
Esophageal web 420 (5.4) 19,930 (0.06)
FTT (Failure to thrive) 270 (3.4) 144,600 (0.5)
Esophageal perforation 60 (0.8) 2300 (0.007)
Barrett’s esophagus 380 (4.8) 107,010 (0.3)
Eosinophilic gastritis 100 (1.3) 480 (0.002)
Eosinophilic colitis 30 (0.4) 540 (0.002)
Allergic Diagnoses2
Allergic condition 5260 (67.1) 7,802,410 (25.3)
Drug allergy 3130 (39.9) 5,802,650 (18.9)
Rhinitis 2750 (35.1) 2,214,140 (7.2)
Asthma 2290 (29.2) 2,383,590 (7.8)
Sinusitis 2270 (29.0) 2,538,420 (8.3)
Dermatitis 2060 (26.3) 2,482,670 (8.0)
Food allergy 1590 (20.3) 646,170 (2.1)
Eczema 1490 (19.0) 1,624,530 (5.3)
Urticaria 380 (4.8) 353,600 (1.1)
Medications
Antihistamines 5500 (70.2)
H2RB 2020 (25.8)
Topical form
corticosteroids
1300 (16.6)
1

p-values (by Pearson Chi-square test) for all GI Diagnoses were <0.0001.

2

p-values (by Pearson Chi-square test) for Allergies Diagnoses were <0.0001.